| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.54M | - | |
| CFO | 215.4K | $1.79M | - | |
| Dir | 119.9K | $998.4K | - | |
| VP | 104.1K | $867.2K | - | |
| Dir | 89.0K | $741.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2018 | Richard Ronald | Director | Sale+OE | 7,893 | $70.00 | $552,510.00 | -27.4% | |
| Nov 7, 2018 | Zoon Kathryn C62 | Director | Sell | 4,242 | $69.74 | $295,855.65 | -9.8% | |
| Nov 6, 2018 | Joulwan George A | Director | Sell | 4,058 | $68.45 | $277,784.30 | -13.4% | |
| Nov 6, 2018 | Harsanyi Zsolt | Director | Sell | 8,000 | $68.90 | $551,193.60 | -19.1% | |
| Nov 2, 2018 | Havey Adam | EVP, Business Operations | Sale+OE | 8,179 | $64.25 | $525,534.50 | -12.3% | |
| Oct 17, 2018 | Havey Adam | EVP, Business Operations | Sale+OE | 314 | $61.50 | $19,311.00 | -1.1% | |
| Oct 16, 2018 | Havey Adam | EVP, Business Operations | Sale+OE | 22,996 | $61.06 | $1,404,025.96 | -13.5% | |
| Sep 17, 2018 | Abdun-Nabi Daniel | CEO | Sale+OE | 29,539 | $65.00 | $1,920,035.00 | -8.1% | |
| Sep 5, 2018 | Abdun-Nabi Daniel | CEO | Sale+OE | 90,776 | $60.18 | $5,463,230.26 | -20.0% | |
| Aug 21, 2018 | Richard Ronald | Director | Sale+OE | 7,893 | $60.02 | $473,709.36 | -15.8% |